Your browser version may not work well with NCBI's Web applications. More information here...
Items 1 - 20 of 550
of 28Next
1:

The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis.

Somoskovi A, Parsons LM, Salfinger M.

Respir Res. 2001;2(3):164-8. Epub 2001 Apr 5. Review.

PMID: 11686881 [PubMed - indexed for MEDLINE]

2:

Primary antituberculosis drug resistance and acquired rifampicin resistance in Gujarat, India.

Trivedi SS, Desai SG.

Tubercle. 1988 Mar;69(1):37-42.

PMID: 3140458 [PubMed - indexed for MEDLINE]

3:

[Resistant tuberculosis: a molecular review]

Rossetti ML, Valim AR, Silva MS, Rodrigues VS.

Rev Saude Publica. 2002 Aug;36(4):525-32. Review. Portuguese.

PMID: 12364929 [PubMed - indexed for MEDLINE]

4:

Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy.

Miotto P, Piana F, Penati V, Canducci F, Migliori GB, Cirillo DM.

J Clin Microbiol. 2006 Jul;44(7):2485-91.

PMID: 16825369 [PubMed - indexed for MEDLINE]

5:

[Trends in tuberculosis treatment duration]

Veziris N, Aubry A, Truffot-Pernot C.

Presse Med. 2006 Nov;35(11 Pt 2):1758-64. Review. French.

PMID: 17086138 [PubMed - indexed for MEDLINE]

6:

Treatment of isoniazid-resistant pulmonary tuberculosis.

Kim YH, Suh GY, Chung MP, Kim H, Kwon OJ, Lim SY, Lim SY, Koh WJ.

BMC Infect Dis. 2008 Jan 23;8:6.

PMID: 18211720 [PubMed - indexed for MEDLINE]

7:

[Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study]

Yoshiyama T, Ogata H, Ito K, Aono A, Wada M.

Kekkaku. 2007 Feb;82(2):95-101. Japanese.

PMID: 17373318 [PubMed - indexed for MEDLINE]

8:

Molecular analysis of rifampin and isoniazid resistance of Mycobacterium tuberculosis clinical isolates in Seville, Spain.

González N, Torres MJ, Aznar J, Palomares JC.

Tuber Lung Dis. 1999;79(3):187-90.

PMID: 10656117 [PubMed - indexed for MEDLINE]

9:

Increasing drug resistance of Mycobacterium tuberculosis isolates in Ontario, Canada, 1987-1998.

Remis RS, Jamieson F, Chedore P, Haddad A, Vernich L.

Clin Infect Dis. 2000 Aug;31(2):427-32. Epub 2000 Aug 16.

PMID: 10987700 [PubMed - indexed for MEDLINE]

10:

Rapid genotypic detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis directly in clinical specimens.

Bang D, Bengård Andersen A, Thomsen VØ.

J Clin Microbiol. 2006 Jul;44(7):2605-8.

PMID: 16825393 [PubMed - indexed for MEDLINE]

11:

Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis.

Hazbón MH, Brimacombe M, Bobadilla del Valle M, Cavatore M, Guerrero MI, Varma-Basil M, Billman-Jacobe H, Lavender C, Fyfe J, García-García L, León CI, Bose M, Chaves F, Murray M, Eisenach KD, Sifuentes-Osornio J, Cave MD, Ponce de León A, Alland D.

Antimicrob Agents Chemother. 2006 Aug;50(8):2640-9.

PMID: 16870753 [PubMed - indexed for MEDLINE]

12:

[Bactericidal therapy in patients with tuberculosis]

Krasnov VA, Ursov IG.

Probl Tuberk Bolezn Legk. 2004;(3):21-6. Russian. No abstract available.

PMID: 15338895 [PubMed - indexed for MEDLINE]

13:

Increasing resistance of M. tuberculosis to anti-TB drugs in Saudi Arabia.

Khan MY, Kinsara AJ, Osoba AO, Wali S, Samman Y, Memish Z.

Int J Antimicrob Agents. 2001 May;17(5):415-8.

PMID: 11337231 [PubMed - indexed for MEDLINE]

14:

[Molecular mechanisms of multidrug resistance in Mycobacterium tuberculosis]

Taniguchi H.

J UOEH. 2000 Sep 1;22(3):269-82. Review. Japanese.

PMID: 11019393 [PubMed - indexed for MEDLINE]

15:

Initial screening for antituberculous drug resistance at an inpatient facility in Leon, Nicaragua.

de la Hoz RE, Waycott S, Garcia D, Melendez R, Bia FJ.

Am J Trop Med Hyg. 1997 Jan;56(1):24-6.

PMID: 9063355 [PubMed - indexed for MEDLINE]

16:

[Study of primary resistance to antitubercular drugs in Galicia]

Alvarez D, Valle JM, Martino MV, Gordo P, Carreira J, Valdés L.

Arch Bronconeumol. 1994 Jun-Jul;30(6):297-300. Spanish.

PMID: 8087389 [PubMed - indexed for MEDLINE]

17:

Evaluation of methods for rapid detection of resistance to isoniazid and rifampin in Mycobacterium tuberculosis isolates collected in the Caribbean.

Akpaka PE, Baboolal S, Clarke D, Francis L, Rastogi N.

J Clin Microbiol. 2008 Oct;46(10):3426-8. Epub 2008 Aug 13.

PMID: 18701663 [PubMed - indexed for MEDLINE]

18:

[Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)]

Smirnova TG, Chernousova LN, Andreevskaia SN, Nikolaeva GM.

Probl Tuberk Bolezn Legk. 2004;(3):32-7. Russian.

PMID: 15338898 [PubMed - indexed for MEDLINE]

19:

[Molecular mechanisms of mycobacterium tuberculosis strains resistance to rifampicin and isoniazid]

Stepanshina VN, Panfertsev EA, Mitrofanova GN, Korobova OV, Stepanshin IuG, Shemiakin IG, Medvedeva IM.

Probl Tuberk. 2000;(1):32-6. Russian.

PMID: 10750428 [PubMed - indexed for MEDLINE]

20:

A continuing survey of drug-resistant tuberculosis, New York City, April 1994.

Fujiwara PI, Cook SV, Rutherford CM, Crawford JT, Glickman SE, Kreiswirth BN, Sachdev PS, Osahan SS, Ebrahimzadeh A, Frieden TR.

Arch Intern Med. 1997 Mar 10;157(5):531-6.

PMID: 9066457 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 550
of 28Next